Ind-Swift Laboratories Limited

NSEI:INDSWFTLAB Stock Report

Market Cap: ₹6.1b

Ind-Swift Laboratories Balance Sheet Health

Financial Health criteria checks 5/6

Ind-Swift Laboratories has a total shareholder equity of ₹10.1B and total debt of ₹164.0M, which brings its debt-to-equity ratio to 1.6%. Its total assets and total liabilities are ₹11.9B and ₹1.8B respectively. Ind-Swift Laboratories's EBIT is ₹941.1M making its interest coverage ratio -7.5. It has cash and short-term investments of ₹4.4B.

Key information

1.6%

Debt to equity ratio

₹163.96m

Debt

Interest coverage ratio-7.5x
Cash₹4.38b
Equity₹10.12b
Total liabilities₹1.76b
Total assets₹11.88b

Recent financial health updates

Recent updates

There Are Some Reasons To Suggest That Ind-Swift Laboratories' (NSE:INDSWFTLAB) Earnings Are A Poor Reflection Of Profitability

Nov 20
There Are Some Reasons To Suggest That Ind-Swift Laboratories' (NSE:INDSWFTLAB) Earnings Are A Poor Reflection Of Profitability

Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Revenues Are Not Doing Enough For Some Investors

Oct 20
Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Revenues Are Not Doing Enough For Some Investors

Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company

Jul 02
Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company

Shareholders In Ind-Swift Laboratories (NSE:INDSWFTLAB) Should Look Beyond Earnings For The Full Story

May 21
Shareholders In Ind-Swift Laboratories (NSE:INDSWFTLAB) Should Look Beyond Earnings For The Full Story

Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Surges 26% Yet Its Low P/E Is No Reason For Excitement

Apr 13
Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Surges 26% Yet Its Low P/E Is No Reason For Excitement

Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly

Dec 28
Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly

These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well

Jul 22
These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Reasonably Well

Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet

Jul 12
Ind-Swift Laboratories (NSE:INDSWFTLAB) Has A Somewhat Strained Balance Sheet

Did Business Growth Power Ind-Swift Laboratories' (NSE:INDSWFTLAB) Share Price Gain of 231%?

Feb 17
Did Business Growth Power Ind-Swift Laboratories' (NSE:INDSWFTLAB) Share Price Gain of 231%?

We're Not So Sure You Should Rely on Ind-Swift Laboratories's (NSE:INDSWFTLAB) Statutory Earnings

Dec 30
We're Not So Sure You Should Rely on Ind-Swift Laboratories's (NSE:INDSWFTLAB) Statutory Earnings

These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively

Nov 11
These 4 Measures Indicate That Ind-Swift Laboratories (NSE:INDSWFTLAB) Is Using Debt Extensively

Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?

Jun 27
Is Ind-Swift Laboratories (NSE:INDSWFTLAB) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: INDSWFTLAB's short term assets (₹5.9B) exceed its short term liabilities (₹1.6B).

Long Term Liabilities: INDSWFTLAB's short term assets (₹5.9B) exceed its long term liabilities (₹121.3M).


Debt to Equity History and Analysis

Debt Level: INDSWFTLAB has more cash than its total debt.

Reducing Debt: INDSWFTLAB's debt to equity ratio has reduced from 188.2% to 1.6% over the past 5 years.

Debt Coverage: INDSWFTLAB's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: INDSWFTLAB earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies